Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Sizova L: Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs. Br. J. Clin. Pharmacol.66(2),173–178 (2008).
  Medline CASGoogle Scholar
• 2  Van Der Bijl AE, Goekoop-Ruiterman YP, De Vries-Bouwstra JK et al.: Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis. Arthritis Rheum.56(7),2129–2134 (2007).
  Medline CASGoogle Scholar
• 3  Zhou H-F, Chan HW, Wickline SA, Lanza GM, Pham CT: α_vβ₃-targeted nanotherapy suppresses inflammatory arthritis in mice. Faseb J.23(9),2978–2985 (2009).▪▪ First study to show that αvβ3-targeted nanoparticles conjugated to fumagillin accumulate specifically in inflamed joints and suppress the progression of experimental arthritis.
  Medline CASGoogle Scholar
• 4  Duda DG, Jain RK, Willett CG: Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers. J. Clin. Oncol.25(26),4033–4042 (2007).▪▪ Presents the rationale and current understanding of antiangiogenics and their therapeutic potential in combination with chemoradiotherapy.
  Medline CASGoogle Scholar
• 5  Culy C: Bevacizumab: antiangiogenic cancer therapy. Drugs Today (Barc)41(1),23–36 (2005).
  Medline CASGoogle Scholar
• 6  Fukumura D, Jain RK: Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc. Res.74(2–3),72–84 (2007).
  Medline CASGoogle Scholar
• 7  Winter PM, Caruthers SD, Zhang H, Williams TA, Wickline SA, Lanza GM: Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. JAAC Cardiovasc. Imaging1(5),624–634 (2008).▪▪ Shows that integrin-targeted fumagillin nanoparticles can induce sustained antiangiogenic response in a model of atherosclerosis when combined with a statin.
  MedlineGoogle Scholar
• 8  Adkison AM, Raptis SZ, Kelley DG, Pham CT: Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J. Clin. Invest.109(3),363–371 (2002).
  Medline CASGoogle Scholar
• 9  Schnell MA, Hardy C, Hawley M, Propert KJ, Wilson JM: Effect of blood collection technique in mice on clinical pathology parameters. Human Gene Ther.13(1),155–161 (2002).
  Medline CASGoogle Scholar
• 10  Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA: Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist. J. Clin. Invest.103(1),47–54 (1999).
  Medline CASGoogle Scholar
• 11  Bulte JWM, Lanza GM, Fuhrhop RW et al.: Gd-DTPA perfluorocarbon emulsions as a novel paramagnetic particulate contrast medium: T1 and T2 relaxometry. Presented at: Proceedings of International Society for Magnetic Resonance in Medicine 6th Annual Meeting. Sydney, Australia, 18–24 April (1998) (Abstract 209).
  Google Scholar
• 12  Lena N, Imbert AM, Brunet P, Cano JP, Carcassonne Y: Kinetics of methotrexate and its metabolites in red blood cells. Cancer Drug Deliv.4(2),119–127 (1987).
  Medline CASGoogle Scholar
• 13  Chan ES, Cronstein BN: Methotrexate – how does it really work? Nat. Rev. Rheumatol.6(3),175–178 (2010).▪ Details the complex and multifaceted mechanisms that make methotrexate efficacious in the treatment of inflammatory disorders.
  Medline CASGoogle Scholar
• 14  Varner JA, Brooks PC, Cheresh DA: Review: The integrin α_vβ₃: angiogenesis and apoptosis. Cell Adhes. Commun.3(4),367–374 (1995).
  Medline CASGoogle Scholar
• 15  Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J: Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation99(13),1726–1732 (1999).
  Medline CASGoogle Scholar
• 16  Brdlik CM, Crews CM: A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases. J. Biol. Chem.279(10),9475–9480 (2004).
  Medline CASGoogle Scholar
• 17  De Bandt M, Grossin M, Weber AJ et al.: Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis. Arthritis Rheum.43(9),2056–2063 (2000).▪ Early report showing that TNP-470, a soluble form of fumagillin, can prevent the development of experimental arthritis.
  Medline CASGoogle Scholar
• 18  Herbst RS, Madden TL, Tran HT et al.: Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer. J. Clin. Oncol.20(22),4440–4447 (2002).
  Medline CASGoogle Scholar
• 19  Neurath MF, Hildner K, Becker C et al.: Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): A mechanism for methotrexate-mediated immunosuppression. Clin. Exp. Immunol.115(1),42–55 (1999).
  Medline CASGoogle Scholar
• 20  Szekanecz Z, Besenyei T, Paragh G, Koch AE: New insights in synovial angiogenesis. Joint Bone Spine77(1),13–19 (2009).
  MedlineGoogle Scholar
• 21  Szekanecz Z, Besenyei T, Szentpetery A, Koch AE: Angiogenesis and vasculogenesis in rheumatoid arthritis. Curr. Opin. Rheum.22(3),299–306 (2010).▪ Provides a current understanding of the role of angiogenesis in rheumatoid arthritis, and summarizes the possibilities of therapeutic intervention.
  Medline CASGoogle Scholar
• 101  BRISTOL-MYERS SQUIBB PHARMA COMPANY: US6511648 (2003).
  Google Scholar
• 201  Image J: image processing and analysis in Java http://rsb.info.nih.gov/ij
  Google Scholar